Astrazeneca AZN
NYSE AZN
$172.60 +4.17 (+2.48%)
At close: Oct 22, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Long-Term Debt Issuances (2009 - 2010)

Updated

Astrazeneca's Long-Term Debt Issuances was $15 million in FY2025, down 99.8% from $6.49 billion in FY2024.

Analysis

Astrazeneca (AZN) Long-Term Debt Issuances (2009 - 2010) Analysis & Trends

From FY2015 onward, Astrazeneca has reported Long-Term Debt Issuances for 10 years.

  • Long-Term Debt Issuances shows a five-year compound annual growth rate of -65.3% (FY2020 to FY2025).
  • The FY2025 figure marks the lowest annual Long-Term Debt Issuances in data going back to FY2015.
  • Per Business Quant data, Long-Term Debt Issuances in earlier years was $6.49 billion in FY2024 (+70.1%), $3.82 billion in FY2023 and $12.93 billion in FY2021 (+335.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Vertex Pharmaceuticals 135.58 Bn 107.59 Bn 2.84 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2010 -9.22 Bn
Dec 31, 2009 -11.06 Bn
API Access

Astrazeneca Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=AZN&period=max&api_key=YOUR_API_KEY